Contact Us
Quotes News NAV
Market Watch
25 Apr EOD
SENSEX
NIFTY
GOLD
SILVER
CRUDE OIL
 
Market Info EXPAND TICKER
You are here : Corporate Information   |  Peer Comparison
Your Result on : Corporate Information | Peer Comparison
Bafna Pharmaceuticals Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)		 NSE
Symbol		 Div Yield
%		 Market Cap
(Rs.Cr)		 P/E
(TTM)		 EPS
(TTM)		 Face Value
(R)
532989 INE878I01022 34.9804545 BAFNAPH 0 188.64 40.48 1.97 10
Option : 
Select Company Name BSE Code NSE Symbol
ABL Bio-Technologies Ltd 526955 Not Listed
ACE Laboratories Ltd 526077 ACELAB
Adline Chem Lab Ltd 524604 Not Listed
Aesculapius Remedies Ltd (Wound-up) 531786 Not Listed
Ahlcon Parenterals (India) Ltd 524448 Not Listed
Ajanta Pharma Ltd 532331 AJANTPHARM
Alpa Laboratories Ltd 532878 ALPA
Alps Laboratories Ltd 526003 Not Listed
American Remedies Ltd (Merged) 531534 Not Listed
Amrutanjan Health Care Ltd 590006 AMRUTANJAN
<< < 12345> >> 
Detailed Quotes
MF Holdings
Company News
Profit and Loss
Quarterly Results
Share Holding Pattern
Deliverable Volumes
Historical Prices
Board of Directors
Director's Report
Peer Comparison
Score Board
Name Change
Financial Ratios
Company Background
Company Snapshot
Balance Sheet
Site Map | Disclaimer | Circular Reports | Research Reports | About Us | Feedback | Careers | Contact Us
Useful Links
Stock : Stock Price Quotes | Stock Market India | Stock Market Global | Corporate Announcement
Market News : Corporate News | Market Commentary | Corporate Results | Economy News | Other Markets | Hot Pursuit | Futures Market
Share Market Updates : BSE Top Gainers - Sensex | NSE Top Gainers - Nifty | BSE Top Losers - Sensex | NSE Top Losers - Nifty | BSE Most Active Scrip by Volume - Sensex |
NSE Most Active Scrip by Volume - Nifty | BSE Most Active Scrip by Value - Sensex | NSE Most Active Scrip by Value - Nifty | Advances and Declinces
Derivatives : Get Quotes | Daily Settlement Prices | Put-Call Ratio | Cost Of Carry
Global Indicator : Stock Market Global | Currency | ADR Prices | FII Investments | Mutual Fund Investments
Services : Equity | Derivatives | Commodities | Mutual Fund | Portfolio Management Services (PMS) | Initial Public Offer (IPO)
Members:
Sebi Regn.No. - BSE : INB010983738 | NSE : INB230983737 | F&O : INF230983737 | NSE Currency: INE230983737 | FMC REGN.MCX : MCX/TCM/CORP/0276 | NCDEX : NCDEX/TCM/CORP/0411
Email ID for redressal of Investor Complaints : investorgrievances@manumangal.com
2012 © MANUBHAI MANGALDAS SECURITIES PVT. LTD All rights reserved Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)